| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |